Aim: To evaluate the efficacy of coblation technology in minimizing postoperative pain and morbidity in pediatric patients undergoing adenoidectomy. Material and Methods: This prospective observational study was conducted over 12 months in the Department of Otolaryngology at a tertiary care hospital. Sixty pediatric patients aged 3 to 12 years, diagnosed with adenoid hypertrophy and experiencing symptoms like nasal obstruction and sleep apnea, were enrolled. Exclusion criteria included bleeding disorders and active infections. All patients underwent coblation adenoidectomy under general anesthesia, performed by the same surgical team to ensure uniformity. Postoperative pain was assessed using Visual Analog and Faces Pain Scales at 6, 12, 24, and 48 hours. Time to resume a normal diet and daily activities was documented. Secondary outcomes included the incidence of complications, frequency of upper respiratory infections within one year, and changes in sleep quality assessed pre- and postoperatively. Results: The study population comprised 41.67% aged 6-8 years, and 58.33% were male. Postoperative pain scores significantly decreased from 5.8 at 6 hours to 1.5 at 48 hours (p=0.02). The mean time to return to a normal diet was 2.1 days, and daily activities resumed in 3.5 days, both statistically significant (p=0.04, p=0.03). Complications were minimal, with an overall rate of 16.67%. The frequency of upper respiratory infections decreased significantly (p=0.01), and sleep quality improved markedly, with reductions in snoring and nighttime awakenings (p=0.01). Conclusion: Coblation adenoidectomy effectively reduces postoperative pain and morbidity, accelerates recovery, and improves long-term outcomes, such as fewer respiratory infections and better sleep quality. This surgical approach is recommended for its safety and efficacy in managing pediatric adenoid hypertrophy.